In a previous study using ovarian cancer cell lines and ovarian orthotopic tumor models, FILIP1L decreased MMP-3, -7, and -9 levels and inhibited cancer cell migration and invasion both in vitro and in vivo [16]. This evidence concerns the gene MMP3 and ovarian cancer.